BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29019871)

  • 1. Despite Diagnostic Morphology, Many Mixed Endometrial Carcinomas Show Unexpected Immunohistochemical Staining Patterns.
    Matrai CE; Pirog EC; Ellenson LH
    Int J Gynecol Pathol; 2018 Sep; 37(5):405-413. PubMed ID: 29019871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical characterization of prototypical endometrial clear cell carcinoma--diagnostic utility of HNF-1β and oestrogen receptor.
    Hoang LN; Han G; McConechy M; Lau S; Chow C; Gilks CB; Huntsman DG; Köbel M; Lee CH
    Histopathology; 2014 Mar; 64(4):585-96. PubMed ID: 24103020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are the uterine serous carcinomas underdiagnosed? Histomorphologic and immunohistochemical correlates and clinical follow up in high-grade endometrial carcinomas initially diagnosed as high-grade endometrioid carcinoma.
    Hu S; Hinson JL; Matnani R; Cibull ML; Karabakhtsian RG
    Mod Pathol; 2018 Feb; 31(2):358-364. PubMed ID: 28984301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomes.
    Alkushi A; Köbel M; Kalloger SE; Gilks CB
    Int J Gynecol Pathol; 2010 Jul; 29(4):343-50. PubMed ID: 20567148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial Carcinomas With Clear Cells: A Study of a Heterogeneous Group of Tumors Including Interobserver Variability, Mutation Analysis, and Immunohistochemistry With HNF-1β.
    Han G; Soslow RA; Wethington S; Levine DA; Bogomolniy F; Clement PB; Köbel M; Gilks B; DeLair D
    Int J Gynecol Pathol; 2015 Jul; 34(4):323-33. PubMed ID: 25851704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
    Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
    Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Use of Napsin A and Glypican 3 to Distinguish Endometrial Clear Cell from Serous and Endometrioid Carcinomas.
    Miller EM; Tymon-Rosario J; Sunkara J; Harmon BE; Karabakhtsian RG; Novetsky AP
    Int J Gynecol Cancer; 2018 Sep; 28(7):1318-1324. PubMed ID: 30036224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases.
    Darvishian F; Hummer AJ; Thaler HT; Bhargava R; Linkov I; Asher M; Soslow RA
    Am J Surg Pathol; 2004 Dec; 28(12):1568-78. PubMed ID: 15577675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Undifferentiated Carcinoma of the Endometrium: An Expanded Immunohistochemical Analysis Including PAX-8 and Basal-Like Carcinoma Surrogate Markers.
    Ramalingam P; Masand RP; Euscher ED; Malpica A
    Int J Gynecol Pathol; 2016 Sep; 35(5):410-8. PubMed ID: 26598976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis.
    Reid-Nicholson M; Iyengar P; Hummer AJ; Linkov I; Asher M; Soslow RA
    Mod Pathol; 2006 Aug; 19(8):1091-100. PubMed ID: 16648864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of immunohistochemistry in differential diagnosis of endometrial carcinoma].
    Wu HW; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):784-8. PubMed ID: 23302346
    [No Abstract]   [Full Text] [Related]  

  • 12. Utility of α-methylacyl-coenzyme-A racemase (p504s) immunohistochemistry in distinguishing endometrial clear cell carcinomas from serous and endometrioid carcinomas.
    Fadare O; Parkash V; Gwin K; Hanley KZ; Jarboe EA; Liang SX; Quick CM; Zheng W; Rawish KR; Hecht JL; Desouki MM
    Hum Pathol; 2013 Dec; 44(12):2814-21. PubMed ID: 24119561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Analysis of Mixed Endometrial Carcinomas Shows Clonality in Most Cases.
    Köbel M; Meng B; Hoang LN; Almadani N; Li X; Soslow RA; Gilks CB; Lee CH
    Am J Surg Pathol; 2016 Feb; 40(2):166-180. PubMed ID: 26492180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations.
    Murali R; Davidson B; Fadare O; Carlson JA; Crum CP; Gilks CB; Irving JA; Malpica A; Matias-Guiu X; McCluggage WG; Mittal K; Oliva E; Parkash V; Rutgers JKL; Staats PN; Stewart CJR; Tornos C; Soslow RA
    Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S40-S63. PubMed ID: 30550483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic and immunohistochemical analyses of endometrial carcinomas: experiences from endometrial biopsies in 358 consultation cases.
    Wei JJ; Paintal A; Keh P
    Arch Pathol Lab Med; 2013 Nov; 137(11):1574-83. PubMed ID: 24168495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Immunohistochemical Markers (HNF-1β, Napsin A, ER, CTH, and ASS1) to Distinguish Endometrial Clear Cell Carcinoma From Its Morphologic Mimics Including Arias-Stella Reaction.
    Ji JX; Cochrane DR; Tessier-Cloutier B; Leung S; Cheng AS; Chow C; Gilks B; Huntsman DG; Hoang LN
    Int J Gynecol Pathol; 2020 Jul; 39(4):344-353. PubMed ID: 31094885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma.
    Soslow RA; Wethington SL; Cesari M; Chiappetta D; Olvera N; Shia J; Levine DA
    Am J Surg Pathol; 2012 Dec; 36(12):1771-81. PubMed ID: 23154767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial Serous Carcinoma With Clear-Cell Change: Frequency and Immunohistochemical Analysis.
    Hariri N; Qarmali M; Fadare O
    Int J Surg Pathol; 2018 Apr; 26(2):126-134. PubMed ID: 28954565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serous versus high-grade endometrioid endometrial carcinoma: immunohistochemistry of RFP is not useful for differentiation.
    Ussakli C; Usubutun A; Dincer N; Dolgun A; Bülbül D; Isikdogan Z; Haberal N; Ozen O; Tezel GG
    Pol J Pathol; 2016; 67(3):221-227. PubMed ID: 28155970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of a novel oncofetal mRNA-binding protein IMP3 in endometrial carcinomas: diagnostic significance and clinicopathologic correlations.
    Li C; Zota V; Woda BA; Rock KL; Fraire AE; Jiang Z; Lu D; Xu B; Dresser K; Lutman CV; Fischer AH
    Mod Pathol; 2007 Dec; 20(12):1263-8. PubMed ID: 17885673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.